Back to ESLA

Estrella Immunopharma, Inc. 8-K

Accession 0001213900-26-003998

Filing information

CIK
0001844417
Report date
2026-01-07
Filing date
2026-01-13
Form
8-K
Primary document
ea027282201-8k_estrellaimmu.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.